| 000 | 01547 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517095950.0 | ||
| 264 | 0 | _c20171201 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1533-1601 | ||
| 024 | 7 |
_a10.1177/0192623316650052 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHalpern, Wendy G | |
| 245 | 0 | 0 |
_aScientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development. _h[electronic resource] |
| 260 |
_bToxicologic pathology _c08 2016 |
||
| 300 |
_a789-809 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aGuideline Adherence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPathology, Clinical _xmethods |
| 650 | 0 | 4 |
_aToxicity Tests _xmethods |
| 650 | 0 | 4 |
_aToxicology _xmethods |
| 700 | 1 | _aAmeri, Mehrdad | |
| 700 | 1 | _aBowman, Christopher J | |
| 700 | 1 | _aElwell, Michael R | |
| 700 | 1 | _aMirsky, Michael L | |
| 700 | 1 | _aOliver, Julian | |
| 700 | 1 | _aRegan, Karen S | |
| 700 | 1 | _aRemick, Amera K | |
| 700 | 1 | _aSutherland, Vicki L | |
| 700 | 1 | _aThompson, Kary E | |
| 700 | 1 | _aTremblay, Claudine | |
| 700 | 1 | _aYoshida, Midori | |
| 700 | 1 | _aTomlinson, Lindsay | |
| 773 | 0 |
_tToxicologic pathology _gvol. 44 _gno. 6 _gp. 789-809 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0192623316650052 _zAvailable from publisher's website |
| 999 |
_c26067729 _d26067729 |
||